货号:A320722
同义名:
左旋茶氨酸
/ L-Glutamic Acid γ-ethyl amide; Nγ-Ethyl-L-glutamine
Theanine是一种氨基酸,通常在茶叶中发现,它能与微摩尔范围内的离子型谷氨酸受体结合,包括AMPA受体和NMDA受体。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | L-Theanine is an amino acid ingredient in green tea with a structural analogy to L-glutamine. L-Theanine accumulation consisted of at least two different components with Km values of 42.3 µM and 1.88 mM, and Vmax values of 3.92 and 104.2 nmol/h/mg protein, respectively. L-Theanine efficiently suppressed elevations of systemic blood pressure and brain 5-hydroxyindoles levels in spontaneous hypertensive rats.A prior intracerebroventricular injection of L-Theanine protected the hippocampal CA1 pyramidal neurons against delayed neuronal cell death in gerbils with bilateral forebrain global ischemia[3]. |
| Concentration | Treated Time | Description | References | |
| Tea plant seedlings | 0.1, 1, 5 mM | 14 days | Theanine inhibited lateral root development | Hortic Res. 2022 Dec 2;10(2):uhac267 |
| Arabidopsis seedlings | 0.01, 0.1, 1, 5 mM | 2 days | Theanine inhibited lateral root development | Hortic Res. 2022 Dec 2;10(2):uhac267 |
| B16F10 murine melanoma cells | 0.6-3 mM | 24 hours | To evaluate the effects of L-theanine on melanogenesis, results showed that L-theanine significantly reduced intracellular tyrosinase activity and melanin content. | Molecules. 2025 Feb 19;30(4):956 |
| AML12 cells | 1-4 mM | 24 hours | Theanine significantly alleviated OA-induced steatosis in AML12 cells and reduced intracellular TG levels. | Nutr Metab (Lond). 2022 Apr 15;19(1):29 |
| HepG2 cells | 1-4 mM | 24 hours | Theanine significantly alleviated OA-induced steatosis in HepG2 cells and reduced intracellular TG levels. | Nutr Metab (Lond). 2022 Apr 15;19(1):29 |
| Rat primary chondrocytes | 50, 100, 200 µM | 24 hours | L-theanine dose-dependently decreased mRNA and protein levels of MMP-3 and MMP-13, as well as the expression of COX-2 and iNOS in IL-1β-stimulated chondrocytes, and reduced the secretion of PGE-2 and NO in the culture supernatant. | Nutrients. 2020 Jul 3;12(7):1988 |
| Botrytis cinerea | 5 mM | 7 days | To evaluate the antifungal activity of theanine against Botrytis cinerea in vitro. Results showed that 5 mmol L−1 theanine treatment significantly inhibited the mycelial growth of B. cinerea, reducing the colony diameter by 18%. | Food Chem X. 2024 Aug 24;23:101772 |
| Administration | Dosage | Frequency | Description | References | ||
| Zebrafish | Zebrafish larvae | Added to culture media | <2 mg/mL | 48 hours | To evaluate the inhibitory effect of L-theanine on melanogenesis in zebrafish, results showed that L-theanine significantly reduced melanin production. | Molecules. 2025 Feb 19;30(4):956 |
| Tea plant | Seedlings | Hydroponic solution | 1 mM | 14 days | Theanine inhibited lateral root development by modulating H2O2 accumulation | Hortic Res. 2022 Dec 2;10(2):uhac267 |
| C57BL/6J mice | Myocardial ischemia-reperfusion injury model | Intraperitoneal injection | 10 mg/kg | Once daily for seven days | Theanine attenuates myocardial ischemia-reperfusion injury by suppressing oxidative stress and apoptosis, partially through activation of the JAK2/STAT3 signaling pathway. | Mol Med. 2024 Jun 28;30(1):98 |
| Male Sprague Dawley rats | Adolescent THC exposure model | Intraperitoneal injection | 10 mg/kg | Twice daily from P35 to P45 | L-theanine pretreatment before adolescent THC exposure is capable of preventing long-term, THC-induced dysregulation of both PFC and VTA DAergic activity states, a neuroprotective effect that persists into adulthood. In addition, pretreatment with L-theanine blocked THC-induced down-regulation of local GSK-3 (glycogen synthase kinase 3) and Akt signaling pathways directly in the PFC, two biomarkers previously associated with cannabis-related psychiatric risk and subcortical DAergic dysregulation. Finally, L-theanine powerfully blocked the development of both affective and cognitive abnormalities commonly associated with adolescent THC exposure, further demonstrating functional and long-term neuroprotective effects of L-theanine in the mesocorticolimbic system. | J Neurosci. 2021 Jan 27;41(4):739-750 |
| C57BL/6 mice | IMQ-induced psoriasis like skin inflammation model | Topical application | 10 mM or 100 mM | Twice per day for five consecutive days | Theanine significantly alleviated IMQ-induced psoriasis like skin inflammation, reducing epidermal thickness and inflammatory response | Front Pharmacol. 2021 Jul 26;12:719842 |
| Tea plants (Camellia sinensis L.) | Salt stress model | Nutrient solution treatment | 10 mM theanine | 3 days | Theanine improves salt stress tolerance via modulating redox homeostasis in tea plants | Front Plant Sci. 2021 Oct 15;12:770398 |
| C57BL/6 male mice | Acute alcoholic intestinal injury model | Oral | 100, 200, and 400 mg/kg/day | Once daily for 28 days | Theanine mitigates acute alcoholic intestinal injury by activating the HIF-1 signaling pathway to regulate the TLR4/NF-κB/HIF-1α axis. | Nutrients. 2025 Feb 18;17(4):720 |
| Mice | Healthy mice | Gavage | 100, 300, 400 mg/kg/d | Once daily for 28 days | LTA supplementation not only affects serum alkaline phosphatase (AKP), total protein (TP), and urea nitrogen (BUN) levels, but it also upregulates the mRNA and protein expression of amino acid transporters (EAAT3, EAAT1, 4F2hc, y+LAT1, CAT1, ASCT2, and B0AT1), and activates the mTOR signaling pathway. | Nutrients. 2022 Dec 28;15(1):142 |
| Mice | DdY mice | Drinking water | 20 µg/mL | Continued for 6 months | Theanine intake significantly suppressed adrenal hypertrophy in the group-housed older mice and reduced the expression of holo-GR and Dnmt3a in the hippocampus, potentially reversing the repressed state of Npas4 transcription. | Int J Mol Sci. 2023 Feb 16;24(4):3983 |
| Sprague-Dawley rats | Doxorubicin-induced ovarian toxicity model | Oral gavage | 200 mg/kg and 400 mg/kg | Once daily for 3 days | To investigate the protective effects of theanine on doxorubicin-induced ovarian toxicity, results showed that theanine ameliorated ovarian damage by reducing oxidative stress, inflammation, and endoplasmic reticulum stress. | Food Sci Nutr. 2025 Apr 24;13(4):e70150 |
| Spontaneously hypertensive rats | Spontaneously hypertensive rats | Oral | 27 µg/mL | Free access to drinking, for 6 weeks | L-theanine contributes to the prevention of bladder dysfunctions by inhibiting chronic sympathetic hyperactivity and protecting bladder contractility | Metabolites. 2021 Nov 14;11(11):778 |
| Wistar rats | Vincristine-induced neuropathy model | Intraperitoneal injection | 30, 100, and 300 mg/kg/day | Once daily for 21 days | Theanine significantly alleviated vincristine-induced neuropathy, including hyperalgesia, allodynia, and nerve functional loss, through its antioxidative, calcium homeostasis, anti-inflammatory, anti-apoptotic, and neuroprotective properties. | Antioxidants (Basel). 2023 Mar 25;12(4):803 |
| C57BL/6J mice | High-fat diet-induced nonalcoholic fatty liver model | Gavage | 300 mg/kg | Once daily for 16 weeks | Theanine significantly reduced body weight gain, hepatic steatosis, and serum levels of ALT, AST, TG, and LDL-C in HFD-induced mice. | Nutr Metab (Lond). 2022 Apr 15;19(1):29 |
| Strawberry (Fragaria × ananassa Duch. cv. 'Hongyan') | Botrytis cinerea inoculation model | Immersion | 5 mM | Single treatment, lasting 5 days | To evaluate the effect of theanine on controlling gray mold in strawberries. Results showed that 5 mmol L?1 theanine treatment significantly reduced the disease incidence and severity of gray mold and maintained higher fruit firmness. | Food Chem X. 2024 Aug 24;23:101772 |
| Caenorhabditis elegans | Ultraviolet C (UVC)-exposed nematode model | Administered via K agar plates | 50 µg/mL | Continuous for 48 hours | L-theanine treatment enhanced the removal of mtDNA damage and extended lifespan by activating autophagy, mitophagy, mitochondrial dynamics, and mitochondrial unfolded protein response (UPRmt) in UVC-exposed nematodes. | Molecules. 2024 Jun 6;29(11):2691 |
| Sprague Dawley (SD) rats | Anterior cruciate ligament transection (ACLT)-induced osteoarthritis model | Oral gavage | 50, 100, 200 mg/kg | Once daily for 6 weeks | L-theanine significantly alleviated ACLT-induced OA lesions, reduced OARSI scores, decreased serum levels of C2C and CTX-II, and lowered the expression of COX-2, PGE-2, iNOS, and NO. | Nutrients. 2020 Jul 3;12(7):1988 |
| Mice | Stress-loaded mouse model | Oral | 6 mg/kg | Two months | Theanine intake improved depression-like behavior in stress-loaded mice and modulated hippocampal metabolite levels. | Int J Mol Sci. 2020 Dec 28;22(1):193 |
| Mice | SAMP10 and ddY mice | Oral | 6 mg/kg | Continuous intake | Theanine intake suppressed stress-induced brain atrophy and altered the expression of Npas4 and Lcn2. | Nutrients. 2020 Jan 8;12(1):174 |
| C57BL/6J male mice | High-fat diet-induced obese mouse model | Gavage | 900 mg/kg | Once daily for 26 weeks | Theanine ameliorates obesity-related complications induced by high-fat diet in mice by suppressing lipid metabolism and inflammation pathways, including reducing body weight gain, fat deposition, glycolipid metabolism disorders, and hepatic steatosis. | Foods. 2024 Sep 19;13(18):2977 |
| ICR mice and SD rats | Pentobarbital-induced sleep model and caffeine-induced wakefulness model | Oral | GABA/ L-theanine mixture (100/20 mg/kg) | Sleep latency and duration were measured 40 minutes after administration | The GABA/theanine mixture significantly reduced sleep latency and increased sleep duration, showing synergistic effects compared to GABA or theanine alone. | Pharm Biol. 2019 Dec;57(1):65-73 |
| Balb/c mice | Caffeine-induced sleep disturbance model and pentobarbital-induced sleep model | Intraperitoneal injection | L-theanine (20 mg/kg), Mg-T1 (21.74 mg/kg), Mg-T2 (24.39 mg/kg) | Single administration | To investigate the effects of Mg-L-theanine complexes on sleep quality and brain electrical activity. Results showed that Mg-L-theanine complexes, especially those with higher magnesium concentrations, significantly increased the expression of GABAergic, serotonergic, and glutamatergic receptors, decreased ECoG frequency, increased amplitude, enhanced delta wave power, and increased dopamine, serotonin, and melatonin levels while decreasing MDA and increasing antioxidant enzyme levels. | Front Nutr. 2022 Apr 5;9:874254 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.74mL 1.15mL 0.57mL |
28.70mL 5.74mL 2.87mL |
57.41mL 11.48mL 5.74mL |
|
| CAS号 | 3081-61-6 |
| 分子式 | C7H14N2O3 |
| 分子量 | 174.2 |
| SMILES Code | O=C(O)[C@@H](N)CCC(NCC)=O |
| MDL No. | MFCD00059653 |
| 别名 | 左旋茶氨酸 ;L-Glutamic Acid γ-ethyl amide; Nγ-Ethyl-L-glutamine; NSC 21308; 5-N-ethyl-Glutamine; γ-ethylamino-L-Glutamic Acid; L-Theanine |
| 运输 | 蓝冰 |
| InChI Key | DATAGRPVKZEWHA-YFKPBYRVSA-N |
| Pubchem ID | 439378 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
H2O: 150 mg/mL(861.09 mM),配合低频超声助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1